Prof. MURAT TÖRÜNER

Metrics

Publication

192

Publication (WoS)

152

Publication (Scopus)

Citation (WoS)

3338

H-Index (WoS)

Citation (Scopus)

4195

H-Index (Scopus)

Citation (TrDizin)

H-Index (TrDizin)

Citation (Sobiad)

121

H-Index (Sobiad)

Citation (Sum Other)

Project

Thesis Advisory

Open Access

UN Sustainable Development Goals

Education

1999 - 2002

Post Doctorate of Medicine

Ankara University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Turkey

1994 - 1999

Expertise In Medicine

Ankara University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Turkey

1987 - 1993

Undergraduate

Hacettepe University, Tıp Fakültesi, Tıp Pr., Turkey

Dissertations

2002

Post Doctorate of Medicine

Endoskopi ünitesine başvuran hastalarda barrett özofagusu sıklığı ve üst gastrointestinal semptomlarla olan ilişkisi

Ankara University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü

1999

Expertise In Medicine

Hepatik ensefalopatili bir hayvan modelinde opioderjik sistem aktivitesi ölçüsü olarak adenilat siklaz enzim aktivitesinin incelenmesi

Ankara University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü

Foreign Languages

C1 Advanced

English

Research Areas

Medicine

Internal Medicine Sciences

Internal Diseases

Gastroenterology and Hepatology

Health Sciences

Academic Positions

2010 - Continues

Professor

Ankara University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü

2005 - 2010

Associate Professor

Ankara University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü

2003 - 2005

Research Assistant

Mayo Clinic, School Of Medicine, Department Of Gastroenteroloji

2002 - 2005

Expert

Ankara University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü

1999 - 2002

Expert

Ankara University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü

1994 - 1999

Research Assistant

Ankara University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü

1997 - 1998

Research Assistant

Yale University, Üretim Yönetimi, Hepatik Hemodinamik Laboratuvar

Managerial Experience

2008 - 2012

Vice Dean

Ankara University

Courses

Undergraduate

Barsak Hastalıkları

Inflammatory Bowel Diseases

Approach to a patient with GI Bleeding

Inflammatory Bowel Diseases

Barsak Hastalıkları

Fonksiyonel Barsak Hastalıkları

Alt GİS Kanamaları

Supervised Theses

2023

Expertise In Medicine

Biyolojik ajan kullanan inflamatuar barsak hastalarında primer ve sekonder yanıtsızlık oranları ve bu oranlar üzerinde etkili faktörler

Törüner M. (Advisor)

Z.EROĞLU(Student)

2017

Expertise In Medicine

İnflamatuvar barsak hastalığı'nda sitomegalovirus (CMV) enfeksiyonu sıklığı, risk faktörleri ve klinik seyir

TÖRÜNER M. (Advisor)

B.MANTI(Student)

2015

Expertise In Medicine

İnflamatuar barsak hastalığı olan bireylerde hastalık tipi, aktivitesinin cinsel yaşantı ve hayat kalitesi üzerine etkisi

TÖRÜNER M. (Advisor)

E.BULUT(Student)

2011

Expertise In Medicine

Kolorektal kanserlerde vitamin D reseptör ekspresyonunun kolorektal kanserlerde evre ile ilişkisi ve prognoz üzerine etkisi

TÖRÜNER M. (Advisor)

M.SEZGİN(Student)

2011

Expertise In Medicine

İltihabi barsak hastalıklarında interlökin 23 reseptör ve atg16l1 gen polimorfizmleri ve klinikle ilişkisi

TÖRÜNER M. (Advisor)

G.KABAÇAM(Student)

Articles

2025

1. Efficacy and safety of infliximab in patients with autoimmune hepatitis

Efe C., Lytvyak E., EŞKAZAN T., Liberal R., Androutsakos T., Gökçe D., et al.

Hepatology , vol.81, no.6, pp.1660-1670, 2025 (SCI-Expanded, Scopus)

2024

2. Histological and clinical disease progression in patients with metabolic dysfunction-associated steatotic liver disease using paired liver biopsy

Ekelik M., Gokce D. T., Gumussoy M., KİREMİTCİ S., Bodakci E., Yilmaz V., et al.

JOURNAL OF HEPATOLOGY , 2024 (SCI-Expanded)

2024

3. Histological and clinical disease progression in patients with metabolic dysfunction-associated steatotic liver disease using paired liver biopsy

Ekelik M., Gökçe D. T., Gumussoy M., Kiremitçi S., Bodakçi E., Yılmaz V., et al.

JOURNAL OF HEPATOLOGY , vol.80, pp.479, 2024 (SCI-Expanded)

2024

4. DISEASE PROGRESSION IN PATIENTS WITH METABOLIC DYSFUNCTIONASSOCIATED STEATOTIC LIVER DISEASE USING PAIRED LIVER BIOPSY

Turan D., Ekelik M. M., Gumussoy M., Kiremitci S., Bodakci E., Yilmaz V., et al.

GASTROENTEROLOGY , vol.166, no.5, pp.1642, 2024 (SCI-Expanded)

2023

5. The Abdominal Ultrasonography Results of Cappadocia Cohort Study of Turkey Reveals High Prevalence of Fatty Liver

Sezgin O., AKPINAR H., Özer B., TÖRÜNER M., Bal K., Bor S.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.34, no.6, pp.652-664, 2023 (SCI-Expanded)

2023

6. Epigenetics of Inflammatory Bowel Diseases

TÖRÜNER M., Ünal N. G.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.34, no.5, pp.437-448, 2023 (SCI-Expanded)

2023

7. Non-invasive fibrosis markers for assessment of liver fibrosis in chronic hepatitis delta

Kalkan Ç., Yılmaz Y., Erdoğan B. D., SAVAŞ B., Yurdcu E., Çalışkan A., et al.

Journal of Viral Hepatitis , vol.30, no.5, pp.406-416, 2023 (SCI-Expanded)

2023

8. European Crohn's and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation.

Torres J., Chaparro M., Julsgaard M., Katsanos K., Zelinkova Z., Agrawal M., et al.

Journal of Crohn's & colitis , vol.17, pp.1-27, 2023 (SCI-Expanded)

2023

9. Management of iron-deficiency anemia following acute gastrointestinal hemorrhage: A narrative analysis and review.

Lanas A., Andrews J. M., Lau J., Toruner M., Bromley S. E., Gralnek I. M.

Journal of gastroenterology and hepatology , vol.38, no.1, pp.23-33, 2023 (SCI-Expanded)

2022

10. The Impact of Inflammatory Bowel Diseases and Related Medications on COVID-19 Severity and Outcome: A Tertiary Referral Center Experience from Turkey.

Er R. E., Duman S., Bodakçı E., Yarcı B., Soykan A. İ., Törüner M.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.33, no.12, pp.1025-1032, 2022 (SCI-Expanded)

2022

11. Perception of COVID-19 Pandemic Among IBD Clinicians and IBD Surgeons in Black Sea Region: A Cross-Sectional Questionnaire Study.

Celasin H., Törüner M., Aghayeva S., Bayramov N., Vardanyan A., Nanaeva B., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.33, pp.1004-1011, 2022 (SCI-Expanded)

2022

12. Culture media composition influences patient-derived organoids ability to predict therapeutic response in gastrointestinal cancers.

Hogenson T. L., Xie H., Phillips W. J., Toruner M. D., Li J. J., Horn I. P., et al.

JCI insight , vol.7, 2022 (SCI-Expanded)

2022

13. Evaluation of periodontal status and cytokine levels in saliva and gingival crevicular fluid of patients with inflammatory bowel diseases

Enver A., Özmeriç Kurtuluş N., İşler S. Ç., Törüner M., Fidan Ç., Demirci G., et al.

JOURNAL OF PERIODONTOLOGY , vol.93, no.11, pp.1649-1660, 2022 (SCI-Expanded)

2022

14. Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility

Savarino E., Zingone F., Barberio B., Marasco G., AKYÜZ F., AKPINAR H., et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL , vol.10, no.6, pp.556-584, 2022 (SCI-Expanded)

2022

15. Improvement of Work Productivity and Quality of Life with Anti-Tumor Necrosis Factor Treatment Used in Crohn's Disease in Routine Clinical Practice in Turkey

TÖRÜNER M., BAŞARANOĞLU M., ATUĞ Ö., Senturk O., Akyuz F., Cekic C., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.33, no.5, pp.406-413, 2022 (SCI-Expanded)

2021

16. Assessment of Imaging Features of Crohn's Disease with MR Enterography

Onay M., Erden A., Binboga A. B., Altay C. M., Törüner M.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.32, no.8, pp.631-639, 2021 (SCI-Expanded)

2021

17. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease.

Kucharzik T., Ellul P., Greuter T., Rahier J. F., Verstockt B., Abreu C., et al.

Journal of Crohn's & colitis , vol.15, no.6, pp.879-913, 2021 (SCI-Expanded)

2021

18. Natural History of Cirrhosis: Changing Trends in Etiology Over the Years

İDİLMAN R., Aydogan M., Oruncu M. B., Kartal A., ELHAN A. H., Ellik Z., et al.

DIGESTIVE DISEASES , vol.39, no.4, pp.358-365, 2021 (SCI-Expanded)

2021

19. Turkish IBD Organization's Position Statement on Inflammatory Bowel Disease Management Recommendations During COVID-19 Pandemic

TÖRÜNER M., Kalkan I. H., Akyuz F., Tezel A., ÇELİK A. F.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.32, no.6, pp.488-492, 2021 (SCI-Expanded)

2020

20. New Aspects of the Epigenetics of Pancreatic Carcinogenesis.

Toruner M., Fernandez-Zapico M. E., Pin C. L.

Epigenomes , vol.4, no.3, 2020 (ESCI)

2020

21. Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study

Yamamoto-Furusho J. K., Al Harbi O., Armuzzi A., Chan W., de Leon E. P., Qian J., et al.

DIGESTIVE AND LIVER DISEASE , vol.52, no.8, pp.869-877, 2020 (SCI-Expanded)

2019

22. Population-based assessment of gastrointestinal symptoms and diseases: Cappadocia Cohort, Turkey

SEZGİN O., AKARSU M., Ozer B., TÖRÜNER M., BAL K., TÖRÜNER M.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.30, no.12, pp.1009-1022, 2019 (SCI-Expanded)

2019

23. 2019 Expert opinion on biological treatment use in inflammatory bowel disease management

TÖRÜNER M., AKARSU M., Akyuz F., Dagli U., Hamzaoglu H. O., Tezel A., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.30, 2019 (SCI-Expanded)

2019

24. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

Sands B. E., Peyrin-Biroulet L., Loftus E. V., Danese S., Colombel J., TÖRÜNER M., et al.

NEW ENGLAND JOURNAL OF MEDICINE , vol.381, no.13, pp.1215-1226, 2019 (SCI-Expanded)

2019

25. Barriers to prescribing anti-TNF therapy in inflammatory bowel disease (IBD) across newly industrialised emerging market countries: an analysis of the 'EXPLORE' study

Ye B. D., Furusho J. K. Y., Khan M. R. Q., Fadeeva O., Demuth D., Qian J., et al.

JOURNAL OF CROHNS & COLITIS , vol.13, 2019 (SCI-Expanded)

2019

26. The influence of disease type and activity to sexual life and health quality in inflammatory bowel disease

Bulut E. A., TÖRÜNER M.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.30, no.1, pp.33-39, 2019 (SCI-Expanded)

2019

27. Backwash ileitis in ulcerative colitis: Are there MR enterographic features that distinguish it from Crohn disease?

Erden A., KURU ÖZ D., GÜRSOY ÇORUH A., Erden I., Ates F. S. O., TÖRÜNER M.

EUROPEAN JOURNAL OF RADIOLOGY , vol.110, pp.212-218, 2019 (SCI-Expanded, Scopus)

2018

28. COST-EFFECTIVENESS ANALYSIS OF USTEKINUMAB VERSUS ADALIMUMAB, INFLIXIMAB AND VEDOLIZUMAB FOR THE TREATMENT OF PATIENTS WITH MODERATELY TO SEVERE ACTIVE CROHN'S DISEASE FOR TURKEY

Arhan M., Tezel H. A., TÖRÜNER M., Bilaloglu B., Koral S., Ozer E.

VALUE IN HEALTH , vol.21, 2018 (SCI-Expanded)

2018

29. A rare cause of small bowel obstruction

PEKER E., Erden A., Erden I., TÖRÜNER M.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.29, no.2, pp.237-238, 2018 (SCI-Expanded)

2017

30. MR Enterography in Crohn's disease complicated with enteroenteric fistula

Erden A., ÜNAL S., Akkaya H. E., Onay M., TÖRÜNER M., Gencturk Z. B., et al.

EUROPEAN JOURNAL OF RADIOLOGY , vol.94, pp.101-106, 2017 (SCI-Expanded)

2017

31. Diagnosis and treatment of iron deficiency anemia in patients with inflammatory bowel disease and gastrointestinal bleeding: iron deficiency anemia working group consensus report

AKARSU M., Cetiner M., Keshav S., Ormeci N., TÖRÜNER M.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.28, no.2, pp.81-87, 2017 (SCI-Expanded)

2017

32. Anti-TNF treatments in Crohn's disease and improvement in work productivity and quality of life: an observational study from Turkey

TÖRÜNER M., Basaranoglu M., Atug O., Sentruk O., Akyuz F., Unsal B., et al.

JOURNAL OF CROHNS & COLITIS , vol.11, 2017 (SCI-Expanded)

2016

33. Evaluation of Early Atherosclerosis Markers in Patients with Inflammatory Bowel Disease

Ustun Y., Kilincalp S., Coban S., Coskun Y., YÜKSEL İ., ONGUN A., et al.

MEDICAL SCIENCE MONITOR , vol.22, pp.3943-3950, 2016 (SCI-Expanded)

2016

34. Anti-INF-α agents and serum lipids in inflammatory bowel diseases

Kalkan C., Karakaya F., TÖRÜNER M., Cetinkaya H., Soykan I.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY , no.4, 2016 (SCI-Expanded)

2016

35. Association between single nucleotide polymorphisms in prospective genes and susceptibility to ankylosing spondylitis and inflammatory bowel disease in a single centre in Turkey

KÜÇÜKŞAHİN O., ATEŞ A., Turkcapar N., TÖRÜNER M., Turgay M., Duman T., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , no.4, pp.317-324, 2016 (SCI-Expanded)

2015

36. Association of Matrix Metalloproteinases and Their Tissue Inhibitor With Disease Activity and Development in Spondyloarthropathy and Inflammatory Bowel Disease

Elmas D., ŞAHİN A., KÜÇÜKŞAHİN O., Turkcapar N., TÖRÜNER M., Cetinkaya H., et al.

ARCHIVES OF RHEUMATOLOGY , vol.30, no.3, pp.191-197, 2015 (SCI-Expanded)

2015

37. Health Quality and Sexual Dysfunction in Turkish IBD Patients

TÖRÜNER M., Ates E., Kalkan C., Karakaya F., Cetinkaya H., Soykan I.

JOURNAL OF CROHNS & COLITIS , vol.9, 2015 (SCI-Expanded)

2014

38. Autoimmune disease, tumor necrosis factor inhibitors and acute leukemia: possible associations in two patients?

Ozen M., Keskin O., TOPÇUOĞLU P., Ozturk B., Ozgul S., Ilgen U., et al.

LEUKEMIA & LYMPHOMA , vol.55, no.7, pp.1697-1698, 2014 (SCI-Expanded)

2014

39. Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron-containing medicines

Gomollon F., Chowers Y., Danese S., Dignass A., Nielsen O. H., Lakatos P. L., et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.39, no.7, pp.743-744, 2014 (SCI-Expanded)

2014

40. ERAP-1 gene polymorphisms in Turkish patients with inflammatory bowel diseases and anyklosing spondylitis

KÜÇÜKŞAHİN O., Turkcapar N., Ates A., TÖRÜNER M., Duman T., Cetinkaya H., et al.

JOURNAL OF CROHNS & COLITIS , vol.8, 2014 (SCI-Expanded)

2014

41. Prevalence of iron deficiency anemia and iron deficiency in a single center Turkish IBD cohort

TÖRÜNER M., Kalkan C., Keskin O., Cetinkaya H., Soykan I.

JOURNAL OF CROHNS & COLITIS , vol.8, 2014 (SCI-Expanded)

2014

42. Ülseratif kolitli hastalarda displazi varlığı ve displastik mukozada p53 ve Ki 67 ekspresyonu

BEKTAŞ M., SAVAŞ B., ÇETİNKAYA H., TÖRÜNER M., ENSARİ A., DOĞANAY B., et al.

Akademik Gastroenteroloji Dergisi , vol.13, no.2, pp.41-46, 2014 (Peer-Reviewed Journal)

2014

43. The Role of Anti-Cd74 Antibody in The Development of Spondyloarthropathy in Ankylosing Spondylitis and Inflammatory Bowel Disease and Disease Activity

Yurumez S., KÜÇÜKŞAHİN O., Turgay M., ATEŞ A., TÖRÜNER M., Cetinkaya H., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.32, no.4, 2014 (SCI-Expanded)

2014

44. Colorectal cancer in inflammatory bowel disease: Results of the 3rd ECCO pathogenesis scientific workshop (I)

Sebastian S., Hernandez V., Myrelid P., Kariv R., Tsianos E., TÖRÜNER M., et al.

JOURNAL OF CROHNS & COLITIS , vol.8, no.1, pp.5-18, 2014 (SCI-Expanded)

2014

45. The Frequency of Spondyloarthropathy in Inflammatory Bowel Diseases

KÜÇÜKŞAHİN O., ATEŞ A., TÖRÜNER M., Turkcapar N., ŞAHİN A., Turgay M., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.32, no.4, 2014 (SCI-Expanded)

2013

46. The management of iron deficiency in inflammatory bowel disease - an online tool developed by the RAND/UCLA appropriateness method

Reinisch W., Chowers Y., Danese S., Dignass A., Gomollon F., Nielsen O. H., et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.38, no.9, pp.1109-1118, 2013 (SCI-Expanded)

2013

47. The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis

Feagan B. G., Sandborn W. J., D'Haens G., Pola S., McDonald J. W., Rutgeerts P., et al.

Gastroenterology , vol.145, no.1, 2013 (SCI-Expanded)

2013

48. Adsorptive Leukocytapheresis in Inflammatory Bowel Diseases: Our Preliminary Results are Encouraging

TÖRÜNER M., TOPRAK S. K., Mizrak K., Yildirim Y., Bay M., Ayyildiz E., et al.

TURKISH JOURNAL OF HEMATOLOGY , vol.30, no.2, pp.219-220, 2013 (SCI-Expanded)

2012

49. Effects of Helicobacter pylori infection and long-term proton pump inhibitor use on enterochromaffin-like cells

Bektaş M., Saraç N., Çetinkaya H., TÖRÜNER M., ERDEMLİ E., Keskin O., et al.

Annals of Gastroenterology , vol.25, no.2, pp.123-127, 2012 (Scopus)

2012

50. Can azathioprine/6-mercaptopurine treatment be withdrawn in patients with response in ulcerative colitis: What is the most appropriate time for this?

Kabacam G., TÖRÜNER M.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.23, pp.17-20, 2012 (SCI-Expanded)

2012

51. Effects of Helicobacter pylori infection and long-term proton pump inhibitor use on enterochromaffin-like cells.

Bektaş M., Saraç N., Cetinkaya H., Törüner M., Erdemli E., Keskin O., et al.

Annals of gastroenterology , vol.25, no.2, pp.123-127, 2012 (Scopus)

2012

52. How long should we treat patients with azathioprine/6-mercaptopurine before deciding that it is refractory to immunomodulatory treatment?

Kabacam G., TÖRÜNER M.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.23, pp.13-16, 2012 (SCI-Expanded)

2011

53. The Effect of Endogenous Hypergastrinemia on Lower Esophageal Sphincter Pressure and Esophageal Motility

Yakut M., Kabacam G., Bektas M., Cetinkaya H., TÖRÜNER M., Soykan I.

HEPATO-GASTROENTEROLOGY , vol.58, no.112, pp.1989-1992, 2011 (SCI-Expanded)

2011

54. The effect of age and Helicobacter pylori infection on gastric epithelial cell kinetics

Coban S., Soykan I., TÖRÜNER M., AKBULUT H., Atli T., ENSARİ A.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY , vol.35, no.10, pp.661-665, 2011 (SCI-Expanded)

2011

55. Serum connective tissue markers as predictors of advanced fibrosis in patients with chronic hepatitis B and D

Seven G., Karatayli S. C., KÖSE S. K., Yakut M., Kabacam G., TÖRÜNER M., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.22, no.3, pp.305-314, 2011 (SCI-Expanded)

2010

56. Is the prevalence of intestinal metaplasia at the squamocolumnar junction different in patients with progressive sytemic sclerosis?

VARDAR R., Vardar E., TÖRÜNER M.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.21, no.3, pp.251-256, 2010 (SCI-Expanded)

2010

57. The Characteristics and Clinical Outcome of Drug-induced Liver Injury A Single-center Experience

İDİLMAN R., Bektas M., Cinar K., TÖRÜNER M., Cerit E. T., DOĞANAY ERDOĞAN B., et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY , vol.44, no.6, 2010 (SCI-Expanded)

2010

58. The Feasibility of 24 Hour Ambulatory Multichannel Intraluminal Impedance in Patients With Progressive Systemic Sclerosis

Bayrakci B., Yargucu F., Vardar R., Oksel F., TÖRÜNER M.

GASTROENTEROLOGY , vol.138, no.5, 2010 (SCI-Expanded)

2010

59. Sexual Intercourse Does Not Increase the Reflux on Patients With Gastroesophageal Reflux Disease

TÖRÜNER M., Vardar R., Valytova E., Belen E.

GASTROENTEROLOGY , vol.138, no.5, 2010 (SCI-Expanded)

2010

60. The Impact of the Speed of Food Intake on Intraesophageal Reflux Events in Obese Female Patients

Vardar R., Valytova E., Belen E., Bayrakci B., TÖRÜNER M.

GASTROENTEROLOGY , vol.138, no.5, 2010 (SCI-Expanded)

2010

61. Proteasome Inhibitor Bortezomib Decreases Mouse Colitis-Associated Tumor Formation

TÖRÜNER M., Nalluri M. K., Han J. J., Sanderson S., Inderhaug C., Callagy G., et al.

GASTROENTEROLOGY , vol.138, no.5, 2010 (SCI-Expanded)

2010

62. What is the importance of anti-TNF agents in the treatment of luminal (inflammatory type) Crohn's disease?

Kabacam G., TÖRÜNER M.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.21, no.1, pp.107-112, 2010 (SCI-Expanded)

2010

63. Prevalence of gastroesophageal reflux disease in patients with asthma and chronic obstructive pulmonary disease

TÖRÜNER M., KİTAPÇIOĞLU G., Solak Z. A., Ertilav M., ERDİNÇ M.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY , vol.25, no.2, pp.309-313, 2010 (SCI-Expanded)

2010

64. The frequency of sexual-physical abuse history in irritabl bowel syndrome patients and diagnostic relation with major depressive disorder history

EKER M. Ç., KASAP E., ELBİ H., TÖRÜNER M.

ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY , vol.11, no.2, pp.120-126, 2010 (SCI-Expanded)

2010

65. Ankara Üniversitesi Tıp Fakültesi Hastaneleri'nde Maliyet Analizi

ESATOĞLU A. E., AĞIRBAŞ İ., Payzıner P. D., AKBULUT Y., GÖKTAŞ B., Ozatkan Y., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.63, no.1, pp.17-27, 2010 (Peer-Reviewed Journal)

2010

66. Cost Analysis in Ankara University School of Medicine Hospitals

Esatoğlu A. E., Ağırbaş İ., Doğanay Payziner P., Akbulut Y., Göktaş B., Özatkan Y., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.63, no.1, pp.17-27, 2010 (Peer-Reviewed Journal)

2009

67. Esophageal intramural pseudodiverticulosis associated with achalasia: an unusual endoscopic appearance

TURAN İ., Ozen E., TÖRÜNER M., Ozutemiz O.

ENDOSCOPY , vol.41, 2009 (SCI-Expanded)

2009

68. Validity and Reliability of a Turkish Version of the Fecal Incontinence Quality of Life Scale

Dedeli O., Fadiloglu C., TÖRÜNER M.

JOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING , vol.36, no.5, pp.532-538, 2009 (SCI-Expanded)

2009

69. The evaluation of VEGF and endostatin expressions and serum levels in ulcerative colitis

Savas B., Kahramanoglu E., Ustun Y., Cetinkaya H., TÖRÜNER M., Ozden A., et al.

VIRCHOWS ARCHIV , vol.455, pp.125-126, 2009 (SCI-Expanded)

2009

70. The additive effect of ethanol and extract of cigarette smoke on rabbit esophagus epithelium

TÖRÜNER M., Capanoglu D.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY , vol.24, no.2, pp.316-321, 2009 (SCI-Expanded)

2009

71. Eating Disorder Symptoms Improved by Antireflux Surgery: A Case Report with a Six-Year Follow Up

Eraslan D., Ozturk O., TÖRÜNER M.

ISRAEL JOURNAL OF PSYCHIATRY AND RELATED SCIENCES , vol.46, no.3, pp.231-235, 2009 (SCI-Expanded)

2008

72. Low prevalence of erosive esophagitis and Barrett esophagus in a tertiary referral center in Turkey

Bayrakci B., Kasap E., Kitapcioglu G., TÖRÜNER M.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.19, no.3, pp.145-151, 2008 (SCI-Expanded)

2008

73. Effects of polymorphism in G2677T/A triallelic region of MDR1 gene in Turkish patients with inflammatory bowel disease

Sapmaz A., Karatayli S. C. O., Dagli U., Kilic Z. M. Y., TÖRÜNER M., Celik Y., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.19, no.3, pp.168-173, 2008 (SCI-Expanded)

2008

74. Risk factors for opportunistic infections in patients with inflammatory bowel disease

TÖRÜNER M., Loftus E. V., Harmsen W. S., Zinsmeister A. R., Orenstein R., Sandborn W. J., et al.

GASTROENTEROLOGY , vol.134, no.4, pp.929-936, 2008 (SCI-Expanded)

2008

75. Endoscopic findings of gastroesophageal reflux disease in Turkey: Multicenter prospective study (Gorhen)

TÖRÜNER M., Vardar R., Vardar E., Takamz S., Mungan Z. A.

GASTROENTEROLOGY , vol.134, no.4, 2008 (SCI-Expanded)

2008

76. PREVALANCE OF FECAL INCONTINENCE AND ITS EFFECT ON QUALITY OF LIFE IN ELDERLY INDIVIDUALS LIVING IN NURSING HOMES IN THE CITY OF IZMIR

Dedeli O., Fadiloglu C., TURAN İ., TÖRÜNER M.

TURK GERIATRI DERGISI-TURKISH JOURNAL OF GERIATRICS , vol.11, no.1, pp.33-41, 2008 (SCI-Expanded)

2007

77. Aspirin and gastrointestinal toxicity

TÖRÜNER M.

ANATOLIAN JOURNAL OF CARDIOLOGY , vol.7, pp.27-30, 2007 (SCI-Expanded)

2007

78. Prevalence patterns of gastric cancers in Turkey: Model of a developing country with high occurrence of Helicobacter pylori

TÖRÜNER M., Vardar R., Ormeci N., Memik F., Suleymanlar I., Oguz D., et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY , vol.22, no.12, pp.2242-2245, 2007 (SCI-Expanded)

2007

79. The acute effect of oral ethanol intake on gastric myoelectrical activity in healthy volunteers

Kobak A. C., TÖRÜNER M.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.18, no.4, pp.221-224, 2007 (SCI-Expanded)

2007

80. Association of heartburn during pregnancy with the risk of gastroesophageal reflux disease

TÖRÜNER M., Kitapcioglu G., Dettmar P., Baxter T.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , vol.5, no.9, pp.1035-1039, 2007 (SCI-Expanded)

2007

81. The effect of laparoscopic Nissen fundoplication on laryngeal findings and voice quality

Ogut F., Ersin S., Engin E. Z., Kirazli T., Midilli R., Unsal G., et al.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES , vol.21, no.4, pp.549-554, 2007 (SCI-Expanded)

2007

82. Overlap of symptoms of dyspepsia and gastroesophageal reflux in the community

Kitapcioglu G., MANDIRACIOĞLU A., BOR C., TÖRÜNER M.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.18, no.1, pp.14-19, 2007 (SCI-Expanded)

2007

83. Does an acute increase of intraabdominal pressure effect esophageal sphincter pressure?

Yimaz N., Musoglu A., ÖNER K. S., TÖRÜNER M.

HEPATO-GASTROENTEROLOGY , vol.54, no.74, pp.434-437, 2007 (SCI-Expanded)

2007

84. Methodology and possibilities of manometry in the diagnosis of esophageal disease

Bordin D. S., TÖRÜNER M., Vasilyev Y. V.

TERAPEVTICHESKII ARKHIV , vol.79, no.4, pp.63-71, 2007 (SCI-Expanded)

2007

85. Use of case-based exams as an instructional teaching tool to teach clinical reasoning

Durak H. I., ÇALIŞKAN S. A., TÖRÜNER M., Van der Vleuten C.

MEDICAL TEACHER , vol.29, no.6, 2007 (SCI-Expanded)

2006

86. Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease

Celik Y., Dagli U., Kilic M., TÖRÜNER M., Ozen S., Ozkan M. M., et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY , vol.41, no.5, pp.559-565, 2006 (SCI-Expanded)

2006

87. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease

Turkcapar N., TÖRÜNER M., Soykan I., Aydintug O., Cetinkaya H., Duzgun N., et al.

RHEUMATOLOGY INTERNATIONAL , vol.26, no.7, pp.663-668, 2006 (SCI-Expanded)

2006

88. NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphisms in Turkish patients with inflammatory bowel disease

Ozen S. C., Dagli U., Kilic M. Y., TÖRÜNER M., Celik Y., Ozkan M., et al.

JOURNAL OF GASTROENTEROLOGY , vol.41, no.4, pp.304-310, 2006 (SCI-Expanded)

2006

89. Antianoikis effect of nuclear factor-kappa B through up-regulated expression of osteoprotegerin, BCL-2, and IAP-1

TÖRÜNER M., Fernandez-Zapico M., Sha J., Pham L., Urrutia R., Egan L.

JOURNAL OF BIOLOGICAL CHEMISTRY , vol.281, no.13, pp.8686-8696, 2006 (SCI-Expanded)

2006

90. NF-kappa B signaling - Pros and cons of altering NF-kappa B as a therapeutic approach

Egan L. J., TÖRÜNER M.

INFLAMMATORY BOWEL DISEASE: GENETICS, BARRIER FUNCTION, IMMUNOLOGIC MECHANISMS, AND MICROBIAL PATHWAYS , vol.1072, pp.114-122, 2006 (SCI-Expanded)

2005

91. Preswallowing dystonia

Ertekin C., Aydogdu I., Ozdemirkiran T., Secil Y., TÖRÜNER M.

DYSPHAGIA , vol.20, no.1, pp.15-18, 2005 (SCI-Expanded)

2005

92. Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacter pylori eradication

Duman D., TÖRÜNER M., Ozutemiz O., Sahin T., Oguz D., Isitan F., et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.17, no.12, pp.1357-1361, 2005 (SCI-Expanded)

2005

93. Eosinophil infiltration of the oesophageal mucosa in patients with pollen allergy during the season

Onbasi K., Sin A., Doganavsargil B., Onder G., TÖRÜNER M., Sebik F.

CLINICAL AND EXPERIMENTAL ALLERGY , vol.35, no.11, pp.1423-1431, 2005 (SCI-Expanded)

2005

94. Swallow-induced syncope in a patient with achalasia

TURAN İ., Ersoz G., TÖRÜNER M.

DYSPHAGIA , vol.20, no.3, pp.238-240, 2005 (SCI-Expanded)

2005

95. Endoscopic factors in the diagnosis of colorectal dysplasia in chronic inflammatory bowel disease

TÖRÜNER M., Harewood G., Loftus E., Sandborn W., Tremaine W., Faubion W., et al.

INFLAMMATORY BOWEL DISEASES , vol.11, no.5, pp.428-434, 2005 (SCI-Expanded)

2005

96. Manometric assessment of esophageal motility in patients with primary Sjorgren's syndrome

Turk T., Pirildar T., Tunc E., TÖRÜNER M., Doganavsargil E.

RHEUMATOLOGY INTERNATIONAL , vol.25, no.4, pp.246-249, 2005 (SCI-Expanded)

2005

97. Lamivudine vs lamivudine and interferon combination treatment of HBeAg(-) chronic hepatitis B

Yurdaydin C., Bozkaya H., Cetinkaya H., Sahin T., Karaoguz D., TÖRÜNER M., et al.

Journal of Viral Hepatitis , vol.12, no.3, pp.262-268, 2005 (SCI-Expanded)

2005

98. Gastroesophageal reflux disease in a low-income region in Turkey

TÖRÜNER M., Mandiracioglu A., Kitapcioglu G., Caymaz-Bor C., Gilbert R.

AMERICAN JOURNAL OF GASTROENTEROLOGY , vol.100, no.4, pp.759-765, 2005 (SCI-Expanded)

2004

99. Metalloprotease disintegrin-mediated ectodomain shedding of EGFR ligands promotes intestinal epithelial restitution

Myhre G., TÖRÜNER M., Abraham S., Egan L.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY , vol.287, no.6, 2004 (SCI-Expanded)

2004

100. Factor V Leiden, prothrombin G20210A and MTHFR gene mutations in inflammatory bowel disease.

TÖRÜNER M., Erkan Ö., Soykan I., Bozdayi M., Çetinkaya H., Yurdaydin C., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.15, no.4, pp.250-2, 2004 (Scopus)

2004

101. The effect of rabeprazole alone or in combination with H2 receptor blocker on intragastric pH: a pilot study.

TÖRÜNER M., Bektaş M., Çetinkaya H., Soykan I., Özden A.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.15, no.4, pp.225-8, 2004 (Scopus)

2004

102. Barrett's esophagus: Prevalence and its relationship with dyspeptic symptoms

TÖRÜNER M., Soykan I., Ensari A., KUZU I., Yurdaydin C., Ozden A.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY , vol.19, no.5, pp.535-540, 2004 (SCI-Expanded)

2004

103. Colorectal cancer surveillance in inflammatory bowel diseases

TÖRÜNER M.

Turkish Journal of Cancer , vol.34, no.2, pp.55-59, 2004 (Scopus)

2004

104. Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies

Idilman R., Arat M., Soydan E., TÖRÜNER M., Soykan I., Akbulut H., et al.

JOURNAL OF VIRAL HEPATITIS , vol.11, no.2, pp.141-147, 2004 (SCI-Expanded)

2004

105. Psychometric and methodological characteristics of a culturally adjusted gastroesophageal reflux disease questionnaire

Kitapcioglu G., Mandiracioglu A., TÖRÜNER M.

DISEASES OF THE ESOPHAGUS , vol.17, no.3, pp.228-234, 2004 (SCI-Expanded)

2003

106. Eosinophilic bronchitis as a cause of chronic cough

Ayik S., KAÇMAZ BAŞOĞLU Ö., Erdinc M., TÖRÜNER M., Veral A., Bilgen C.

RESPIRATORY MEDICINE , vol.97, no.6, pp.695-701, 2003 (SCI-Expanded)

2003

107. The comparison of an empiric proton pump inhibitor trial vs 24-hour double-probe Ph monitoring in laryngopharyngeal reflux

Bilgen C., Ogut F., Kesimli-Dinc H., Kirazli T., TÖRÜNER M.

JOURNAL OF LARYNGOLOGY AND OTOLOGY , vol.117, no.5, pp.386-390, 2003 (SCI-Expanded)

2003

108. Effect of hypo- and hyperthyroidism on gastric myoelectrical activity

Gunsar F., Yilmaz S., TÖRÜNER M., Kumanlioglu K., Cetinkalp S., Kabalak T., et al.

DIGESTIVE DISEASES AND SCIENCES , vol.48, no.4, pp.706-712, 2003 (SCI-Expanded)

2003

109. Reversal of iron deficiency anemia in a patient with gastric antral vascular ectasia treated with cyproheptadine

Soykan I., TÖRÜNER M., Idilman R., Ozden A.

JOURNAL OF CLINICAL GASTROENTEROLOGY , vol.36, no.2, pp.183-184, 2003 (SCI-Expanded)

2002

110. Remission of severe aplastic anemia associated with hepatitis B virus infection after viral clearance - Potential role of lamivudine

Bozkaya H., Yurdaydin C., TÖRÜNER M., Arat M., Bozdayi A., Erekul S., et al.

DIGESTIVE DISEASES AND SCIENCES , vol.47, no.8, pp.1782-1785, 2002 (SCI-Expanded)

2002

111. Is pain experienced during liver biopsy an important factor?

Soykan I., TÖRÜNER M., Sarioglu M., Idilman R.

JOURNAL OF CLINICAL GASTROENTEROLOGY , vol.35, no.1, pp.102-103, 2002 (SCI-Expanded)

2002

112. Is fatigue of cholestasis mediated by altered central serotoninergic neurotransmission?

Celik T., Aslan N., Goren Z., GÜRDAL H., Degim T., TÖRÜNER M., et al.

JOURNAL OF HEPATOLOGY , vol.36, pp.29, 2002 (SCI-Expanded)

2001

113. Repopulation of liver endothelial cells, but not hepatocytes, by allogeneic hematopoietic cell transplants.

Idilman R., Tukun A., Erdem E., Arat M., TÖRÜNER M., Soykan I., et al.

BLOOD , vol.98, no.11, 2001 (SCI-Expanded)

2001

114. B-cell lymphoproliferative and plasma cell disorders in individuals with chronic hepatitis C.

Idilman R., Colantoni A., De Maria N., Alkan S., Nand S., Soykan I., et al.

HEPATOLOGY , vol.34, no.4, 2001 (SCI-Expanded)

2001

115. Is fatigue of cholestasis mediated by altered central serotoninergic neurotransmission?.

Yurdaydin C., Celik T., Goren Z., GÜRDAL H., Degim T., TÖRÜNER M., et al.

HEPATOLOGY , vol.34, no.4, 2001 (SCI-Expanded)

2001

116. Gastroesophageal reflux disease in an urban population in Turkey: A model of a developing nation with high H. pylori prevalence

TÖRÜNER M., Mandiracioglu A., Kitapcioglu G., Caymaz-Bor C., Zeytinoglu H., Gilbert R.

GASTROENTEROLOGY , vol.120, no.5, 2001 (SCI-Expanded)

1999

117. Is administration of n-3 fatty acids by mucosal enema protective against trinitrobenzene-induced colitis in rats?

Yuceyar H., Ozutemiz O., Huseyinov A., Saruc M., Alkanat M., TÖRÜNER M., et al.

PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS , vol.61, no.6, pp.339-345, 1999 (SCI-Expanded)

1999

118. Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat

Shah V., TÖRÜNER M., Haddad F., Cadelina G., Papapetropoulos A., Choo K., et al.

GASTROENTEROLOGY , vol.117, no.5, pp.1222-1228, 1999 (SCI-Expanded)

1999

119. Bioactivation of nitroglycerin and vasomotor response to nitric oxide is impaired in cirrhotic rat livers.

Dudenhoefer A., TÖRÜNER M., Cadelina G., Groszmann R.

HEPATOLOGY , vol.30, no.4, 1999 (SCI-Expanded)

1999

120. Mechanisms of basolateral Na+ transport in rabbit esophageal epithelial cells

Abdulnour-Nakhoul S., TÖRÜNER M., Imeryuz N., Orlando R.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY , vol.276, no.2, 1999 (SCI-Expanded)

1999

121. Esophageal exposure to ethanol increases risk of acid damage in rabbit esophagus

TÖRÜNER M., Bor-Caymaz C., Tobey N., Abdulnour-Nakhoul S., Orlando R.

DIGESTIVE DISEASES AND SCIENCES , vol.44, no.2, pp.290-300, 1999 (SCI-Expanded)

1998

122. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats

Gupta T., TÖRÜNER M., Chung M., Groszmann R.

HEPATOLOGY , vol.28, no.4, pp.926-931, 1998 (SCI-Expanded)

1998

123. Role of nitric oxide

Gupta T., TÖRÜNER M., Groszmann R.

DIGESTION , vol.59, no.4, pp.413-415, 1998 (SCI-Expanded)

1998

124. Impaired nitric oxide release in cirrhotic rat liver.

Haddad F., TÖRÜNER M., Shah V., Gupta T., Groszmann R.

GASTROENTEROLOGY , vol.114, no.4, 1998 (SCI-Expanded)

1996

125. Hemorrhagic cystitis after bone marrow transplantation: The role of electron microscopy in differential diagnosis.

GÜRMAN G., Sencer H., Uysal A., Cinar K., Arslan O., Ozcan M., et al.

BLOOD , vol.88, no.10, pp.3747, 1996 (SCI-Expanded)

Papers Presented at Peer-Reviewed Scientific Conferences

2024

1. Age matters! Defining the diversity in upper gastrointestinal involvement in infammatory bowel disease

Kahraman H., Berber H., Jevtic J., Bol A., Davaji J., Özdemir S., et al.

36th European Congress of Pathology, Florence, Italy, 7 September - 11 October 2024, pp.1-546, (Summary Text)

2022

2. Enflamatuvar Barsak Hastalığı Tanılı Hastalarda Sitomegalovirüs Enfeksiyonlarının Değerlendirilmesi

İNAN M., SARICAOĞLU E. M., ÇINAR G., AKDEMİR İ., GÜLTEN E., ENSARİ A., et al.

10. Türkiye EKMUD Bilimsel Kongresi, 25 - 29 May 2022, (Summary Text)

2022

3. Enflamatuar Barsak Hastalığı Tanılı Hastalarda Sitomegalovirüs Enfeksiyonlarının Değerlendirilmesi

İnan M., Sarıcaoğlu E. M., Çınar G., Akdemir Kalkan İ., Gülten E., Ensari A., et al.

10. Türkiye EKMUD Bilimsel Kongresi, Antalya, Turkey, 25 - 29 May 2022, pp.130, (Full Text)

2020

4. Hermasky-Pudlak Syndrome: A Case Report

TAŞDELEN E., KAPLAN İ., TÖRÜNER M., ILGIN RUHİ H.

1. Bursa Uluslararası Katılımlı Genetik Günleri Dermatogenetik Sempozyumu, Turkey, 9 - 11 January 2020, (Summary Text)

2019

5. Population Based Assesment of Gastrointestinal Symptoms and Diseases: Cappadocia Cohort, Turkey

SEZGİN O., Akpınar H., ÖZER B., TÖRÜNER M., BAL K., BOR S.

UEGW 2019, Barselona, 19 - 23 October 2019, (Summary Text)

2019

6. Incidence and Indicators of Suboptimal Response to Tumor Necrosis Factor Antagonist Therapy in Inflammatory Bowel Disease in Newly Industrialized Countries: Results From the EXPLORE Study

Al Harbi O., Armuzzi A., Chan W., de Leon E. P., Qian J., Shapina M., et al.

Annual Scientific Meeting of the American-College-of-Gastroenterology (ACG), San-Antonio, Northern Mariana Islands, 25 - 30 October 2019, vol.114, (Summary Text)

2019

7. Serum or urinary neopterin which is the best for evaluate disease activity in inflammatory bowel disease?

ÇETİNKAYA H., MELEKOĞLU ELLİK Z., KENARLI K., DUMAN S., EVREN E., KARAHAN Z. C., et al.

Proceedings of the World Congress of Gastroenterology, İstanbul, Turkey, 21 - 24 September 2019, vol.30, pp.810, (Summary Text)

2019

8. EVIDENCE BASED RECOMMENDATIONS FOR THE MANAGEMENT OF ENTEROPATHIC ARTHRITIS: A RHEUMATOLOGY, GASTROENTEROLOGY COLLABORATIVE INITIATIVE

HATEMİ G., AKAR S., AKARSU M., ATAGÜNDÜZ M. P., BENGİ G., CAN G., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, Spain, 12 - 15 June 2019, vol.78, pp.881, (Summary Text)

2018

9. Surgical Rates for Crohn’xxs Disease: A monocentric Cross Section Study from Turkey

Bulat B., Köken e., Bilgiç C., AKYOL C., özel m., Kenarlı K., et al.

Falk Syposium No:213, 5 - 06 October 2018, (Summary Text)

2018

10. Managing IBD in Rheumatic Diseases

TÖRÜNER M.

Ninth International Immunology Summit, 8 - 10 March 2018

2018

11. Managing IBD in Rheumatic Disease

TÖRÜNER M.

Ninth International Immunology Summit, Czech Republic, 8 - 10 March 2018, (Full Text)

2017

12. İNFLAMATUVAR BARSAK HASTALIĞI’NDASITOMEGALOVIRÜS (CMV) ENFEKSIYONU SIKLIĞIRISK FAKTÖRLERI VE KLINIK SEYIR

MANTI B., TÖRÜNER M., KESKİN O.

34. Ulusal Gastroenteroloji Haftası, Turkey, 1 - 06 December 2017, (Summary Text)

2017

13. Cytomegalovirus Infection in IBD: Single Center Experience

Manti B., Keskin O., TÖRÜNER M.

82nd Annual Scientific Meeting of the American-College-of-Gastroenterology (ACG), Florida, United States Of America, 13 - 18 October 2017, vol.112, (Summary Text)

2017

14. Case Report: Post-Liver Transplant Crohn's Disease Refractory to Anti-tumor Necrosis Factor Agents

Yilmaz Y., Keskin O., TÖRÜNER M.

82nd Annual Scientific Meeting of the American-College-of-Gastroenterology (ACG), Florida, United States Of America, 13 - 18 October 2017, vol.112, (Summary Text)

2017

15. Treatment Algorithms in Crohn’xxs disease in daily practice

TÖRÜNER M.

16th International Euroasian Congress of Gastroenterology and Surgery, 27 - 30 April 2017, (Full Text)

2017

16. P401 Anti-TNF treatments in Crohn s disease and improvement in work productivity and quality of life: an observational study from Turkey

TÖRÜNER M., BAŞARANOĞLU M., ATUĞ Ö., ŞENTÜRK Ö., AKYÜZ F., ÜNSAL B., et al.

ECCO (EUROPEAN CROHNS AND COLITIS ORGANISATION), Barcelona, Spain, 15 - 18 February 2017, (Summary Text)

2017

17. Anti-TNF treatments in Crohn’xxs disease and improvement in work productivity and quality of life: an observational study from Turkey

TÖRÜNER M., BAŞARANOĞLU M., ATUĞ Ö., ŞENTÜRK Ö., AKYÜZ F., ÜNSAL B., et al.

JOURNAL OF CROHNS COLITIS, 01 February 2017, vol.11, pp.281, (Summary Text)

2016

18. Inflammatory Bowel Diseases

TÖRÜNER M.

FLORIDA INT UNIVERSITY, DEPT. SURGERY - GRAND ROUNDS, 18 November 2016, (Full Text)

2016

19. Crohn hastalığına bağlı enteroenetrik fistüller MR enterografi kl n k laboratuar ve endoskopi bulgularının değerlendirilmesi

ünal s., AKKAYA H. E., onay m., ÇALIŞKAN KARTAL A., bıyıklı gençtürk z., TÖRÜNER M., et al.

37. Ulusal Radyoloji Kongresi, Turkey, 1 - 05 November 2016, (Full Text)

2016

20. MR enterografi, klinik, laboratuvar ve endoskopik bulguların değerlendirilmesi

ÜNAL S., AKKAYA H. E., ONAY M., ÇALIŞKAN KARTAL A., BIYIKLI GENÇTÜRK Z., TÖRÜNER M., et al.

37. Ulusal Radyoloji Kongresi, Turkey, 1 - 05 November 2016, (Full Text)

2016

21. Serum Vitamin D levels have some effects on Sexual dysfunction and health quality in Turkish IBD patients

TÖRÜNER M., Ateş E., ÇALIŞKAN KARTAL A., ÇETİNKAYA H., SOYKAN A. İ.

IMKASID 2016, 15 - 16 April 2016, (Full Text)

2015

22. ERAP1 Gene polymorphisms in Turkish Patients with inflammatory bowel disease and ankylosing spondylitis

ÇETİNKAYA H., KALKAN Ç., KARAKAYA M. F., ÇALIŞKAN KARTAL A., KÜÇÜKŞAHİN O., BEKTAŞ M., et al.

Falk Symposium No: 200, 16 - 17 October 2015

2015

23. IBD and Behçet s disease

TÖRÜNER M.

PanHellenic IBD Symposium, 5 - 06 June 2015

2015

24. Health Quality and Sexual Dysfunction in Turkish IBD Patients

TÖRÜNER M., Ateş E., KALKAN Ç., KARAKAYA M. F., ÇETİNKAYA H., SOYKAN A. İ.

ECCO, 1 - 05 February 2015

2014

25. ASSOCIATION BETWEEN SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS) IN PROSPECTIVE GENES AND SUSCEPTIBILITY TO ANKYLOSING SPONDYLITIS, INFLAMMATORY BOWEL DISEASE IN A TURKISH POPULATION

KÜÇÜKŞAHİN O., Ates A., Turkcapar N., TÖRÜNER M., Duman T., Sahin A., et al.

15th Annual European Congress of Rheumatology (EULAR), Paris, France, 11 - 14 June 2014, vol.73, pp.807, (Summary Text)

2014

26. THE FREQUENCY OF SPONDYLOARTHROPATHY IN INFLAMMATORY BOWEL DISEASES

KÜÇÜKŞAHİN O., Ates A., TÖRÜNER M., Turkcapar N., Sahin A., Turgay M., et al.

15th Annual European Congress of Rheumatology (EULAR), Paris, France, 11 - 14 June 2014, vol.73, pp.1040, (Summary Text)

2014

27. ERAP 1 gene polymorphisms in Turkish patients with inflammatory bowel diseases and ankylosing spondylitis

KÜÇÜKŞAHİN O., TÜRKÇAPAR N., TÖRÜNER M., DUMAN T., ÇETİNKAYA H., TURGAY T. M., et al.

ECCO 2014, 20 - 22 February 2014, vol.32, pp.631, (Summary Text)

2013

28. Tumor necrosis factor inhibitors and acute leukemia in two cases.

Ozen M., Keskin O., KÜÇÜKŞAHİN O., Ilgen U., Topcuoglu P., Turgay M., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31, (Summary Text)

2012

29. Interleukin 23 Receptor, and ATG16L1 Gene Polymorphisms in Inflammatory Bowel Diseases, and the Association With the Clinical Course

Kabacam G., Karatayli S. C., Keskin O., Bektas M., Cetinkaya H., Palabiyikoglu M., et al.

Digestive Disease Week (DDW), California, United States Of America, 19 - 22 May 2012, vol.142, (Summary Text)

2010

30. Cost Analysis in Ankara University School of Medicine Hospitals

ESATOĞLU A. E., AĞIRBAŞ İ., DOĞANAY PAYZİNER P., GÖKTAŞ B., AKBULUT Y., özatkan y., et al.

ISPOR 13th Annual European Congress, 6 - 09 November 2010

2009

31. Clinical and Laboratory Features of Patients with Significantly Elevated Serum Gastrin Level

Kabacam G., Bektas M., Ustun Y., Yakut M., TÖRÜNER M., Cetinkaya H., et al.

Digestive Disease Week/110th Annual Meeting of the American-Gastroenterological-Association, Illinois, United States Of America, 30 May - 04 June 2009, vol.136, (Summary Text)

2008

32. DRUG INDUCED LIVER INJURY: A SINGLE CENTER EXPERIENCE OVER A 7-YEAR PERIOD

Bektas M., Idilmon R., Cerit T., ÇINAR K., TÖRÜNER M., Soykan I., et al.

59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Costa Rica, 31 October - 04 November 2008, vol.48, (Summary Text)

2007

33. Bacterial and viral infections mimicking inflammatory bowel diseases

TÖRÜNER M.

Falk Symposium 159 on IBD 2007 - Achievements in Research and Clinical Practice, İstanbul, Turkey, 4 - 05 May 2007, vol.159, pp.54-59, (Full Text)

2007

34. Comparison of chromoscopic magnifying colonoscopy and convetional colonoscopy for colorectal cancer screening: Preliminary results

Cetinkaya H., Bektas M., Kahramanoglu E., Tuzun A., Savas B., TÖRÜNER M., et al.

Digestive Disease Weeking Meeting/ASGE Postgraduate Course Meeting, Washington, Kiribati, 19 - 24 May 2007, vol.132, (Summary Text)

2007

35. Role of magnifying chromoendoscopy in differentiating adenomatous and non-adenomatous colonic lesions

TÖRÜNER M., Cetinkaya H., Tuzun A. E., Bektas M., Kahramanoglu E., Savas B., et al.

Digestive Disease Weeking Meeting/ASGE Postgraduate Course Meeting, Washington, Kiribati, 19 - 24 May 2007, vol.132, (Summary Text)

2006

36. Increased risk of morbidity associated with immunomodulatory treatment in patients with inflammatory bowel diseases

Colombel J., TÖRÜNER M.

Falk Symposium 153 on Immunoregulation in Inflammatory Bowel Diseases, Berlin, Germany, 6 - 07 May 2006, vol.153, pp.85-98, (Full Text)

2006

37. Risk factors for opportunistic infections in inflammatory bowel diseases: A case-control study

TÖRÜNER M., Loftus E. V., Colombel J. F., Orenstein R., Harmsen W. S., Zinsmeister A. R., et al.

Digestive Disease Week/107th Annual Meeting of the American-Gastroenterological-Association, Los-Angeles, Chile, 19 - 24 May 2006, vol.130, (Summary Text)

2006

38. Chromoscopic magnifying colonoscopy for colorectal cancer screening: Is it a better tool?

Cetinkaya H., Tuzun A., Bektas M., TÖRÜNER M., ENSARİ A., Soykan I., et al.

Digestive Disease Week/107th Annual Meeting of the American-Gastroenterological-Association, Los-Angeles, Chile, 19 - 24 May 2006, vol.130, (Summary Text)

2006

39. The effect of Helicobacter pylori eradication on gastroesophageal reflux, gastrointestinal symptoms and quality of life in patients with functional dyspepsia

Soykan I., Bektas M., TÖRÜNER M., Cetinkaya H., Ozden A.

Digestive Disease Week/107th Annual Meeting of the American-Gastroenterological-Association, Los-Angeles, Chile, 19 - 24 May 2006, vol.130, (Summary Text)

2005

40. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.

Turkcapar N., TÖRÜNER M., Soykan I., Aydintug O., Cetinkaya H., Duzgun N., et al.

69th Annual Scientific Meeting of the American-College-of-Rheumatology/40th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, California, United States Of America, 12 - 17 November 2005, vol.52, (Summary Text)

2005

41. Loss of extracellular attachment triggers an NF-kappa B-mediated survival cascade in intestinal epithelial cells

TÖRÜNER M., Fernandez-Zapico M., Myhre G., Urrutia R., Egan L.

Digestive Disease Week Meeting/106th Annual Meeting of the American-Gastroenterological-Association, Illinois, United States Of America, 14 - 19 May 2005, vol.128, (Summary Text)

2005

42. Does heartburn in pregnancy increase the risk of gastroesophageal reflux disease?

Dettmar P., Kitapcioglu G., TÖRÜNER M.

Annual Meeting of the American-Gastroenterological-Association/Digestive-Disease-Week, Illinois, United States Of America, 14 - 19 May 2005, vol.128, (Summary Text)

2005

43. C-Jun N-terminal inhibits intestinal epithelial cell anoikis downstream of survival factor nk-kappa B

TÖRÜNER M., Egan L.

Digestive Disease Week Meeting/106th Annual Meeting of the American-Gastroenterological-Association, Illinois, United States Of America, 14 - 19 May 2005, vol.128, (Summary Text)

2004

44. Endoscopic factors in the diagnosis of colorectal dysplasia in chronic inflammatory bowel disease

TÖRÜNER M., Harewood G., Loftus E., Sandborn W., Tremaine W., Faubion W., et al.

69th Annual Scientific Meeting of the American-College-of-Gastroentrology, Florida, United States Of America, 29 October - 03 November 2004, vol.99, (Summary Text)

2004

45. Comparison of liver functional parameters with serum fibrosis markers as predictors of severe necro-inflammation in patients with chronic hepatitis B and D

Yurdaydin C., TÖRÜNER M., Bozkaya H., Okcu-Heper A., Voelker M., Erden E., et al.

39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Berlin, Germany, 14 - 18 April 2004, vol.40, pp.133, (Summary Text)

2004

46. Effect of interferon alpha in dextran sulfate sodium induced colitis in mice

Soykan I., TÖRÜNER M., ENSARİ A., Gecim E., Coban S., Cetinkaya H., et al.

Digestive Disease Week/105th Annual Meeting of the American-Gastroenterological-Association, Louisiana, United States Of America, 16 - 19 May 2004, vol.126, (Summary Text)

2003

47. In Sjogren's syndrome gastroesophageal reflux disease is not related with disturbances on gastric myoelectrical activity

Turk T., Celebi A., TÖRÜNER M., Keser G., Kabasakal Y., Doganavsargil E.

Annual European Congress of Rheumatology, Lisbon, Portugal, 18 June 2003, vol.62, pp.463, (Summary Text)

2003

48. The effect of hepatitis B virus status of the donor on the hepatitis B virus serology of the recipient after allogeneic hematopoietic cell transplantation

Idilman R., Soydan E., Arat M., TÖRÜNER M., Soykan I., Karayalcin S., et al.

38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Turkey, 29 March - 01 April 2003, vol.38, pp.146, (Summary Text)

2003

49. Two year interferon treatment of chronic delta hepatitis

Yurdaydin C., Bozkaya H., Erkan O., Karaarslan H., TÖRÜNER M., Cinar K., et al.

38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Turkey, 29 March - 01 April 2003, vol.38, pp.183-184, (Summary Text)

2003

50. Lamivudine prophylaxis for prevention of chemotherapy induced hepatitis B virus reactivation in hepatitis B virus carriers with hematological malignancies

Idilman R., Arat M., TÖRÜNER M., Soykan I., Karayalcin S., Soydan E., et al.

38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Turkey, 29 March - 01 April 2003, vol.38, pp.146-147, (Summary Text)

2003

51. The effect of Saccharomyces boulardii on gastrointestinal symptoms and Helicobacter pylori eradication in patients with functional dyspepsia

Soykan I., TÖRÜNER M., Temizkan A., Ozden A.

Digestive Disease Week 2003 Meeting/104th Annual Meeting of the American-Gastroenterological-Association, ORLANDO, FLORIDA, 17 - 22 May 2003, vol.124, (Summary Text)

2002

52. Is fatigue of cholestasis mediated by altered central serotoninergic neurotransmission?

Celik T., Goren M., Gurdal H., Cinar K., TÖRÜNER M., Degim T., et al.

11th International Symposium on Hepatic Encephalopathy and Nitrogen Metabolism, Amsterdam, Netherlands, 30 May - 01 June 2002, pp.165-171, (Full Text)

2002

53. The efficciency of ursodeoxycholic acid in treatment of limited chronic graft versus host disease of the liver.

Arat M., Idilman R., Soydan E., TÖRÜNER M., Akan H.

44th Annual Meeting of the American-Society-of-Hematology, PHILADELPHIA, PENNSYLVANIA, 6 - 10 December 2002, vol.100, (Summary Text)

2002

54. The long-term ursodeoxycholic acid treatment of chronic graft-versus-host disease of the liver.

Idilman R., Arat M., TÖRÜNER M., Soydan E., Soykan I., Erden E., et al.

53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD), BOSTON, MASSACHUSETTS, 1 - 05 November 2002, vol.36, (Summary Text)

Books

2024

1. İBH'de Ekstraintestinal Bulguların Tedaviye Etkisi

Telli P., Törüner M.

in: İnflamatuvar Bağırsak Hastalığı Uzman Görüş Raporu, AKPINAR HALE,AKYÜZ FİLİZ,ARHAN MEHMET,ÇELİK AYKUT FERHAT,HATEMİ ALİ İBRAHİM,KALKAN İSMAİL HAKKI,KAV TAYLAN,TEZEL HÜSEYİN AHMET,TÖRÜNER MURAT, Editor, İnflamatuvar Barsak Hastalıkları Derneği, İstanbul, pp.138-139, 2024

2024

2. Crohn Hastalığında Tedavi

TELLİ P., TÖRÜNER M.

in: İnflamatuar Bağırsak Hastalıkları Uzman Görüş Raporu, AKPINAR HALE, AKYÜZ FİLİZ, ARHAN MEHMET, ÇELİK AYKUT FERHAT, HATEMİ ALİ İBRAHİM, KALKAN İSMAİL HAKKI, KAV TAYLAN, TEZEL HÜSEYİN AHMET, TÖRÜNER MURAT, Editor, İnflamatuvar Barsak Hastalıkları Derneği, pp.102-111, 2024

2022

3. Inflammatory Bowel Disease

Törüner M.

in: Rare Causes of Stroke, Derya Uluduz,Anita Arsovska, Editor, Cambridge University Press, Cambridge (MA), USA , Cambridge, pp.92-98, 2022

Activities in Scientific Journals

2018 - Continues

FRONTIERS IN MEDICINE

Assistant Editor/Section Editor

2019 - 2023

TURKISH JOURNAL OF GASTROENTEROLOGY

Editor

Memberships and Roles in Scientific Organizations

2023 - Continues

ECCO Clinical Research Committee

Member of Science Committee

2021 - Continues

İnflamatuvar Barsak Hastalıkları Derneği

Vice President

2017 - Continues

European Crohn's and Colitis Asscoiation

Member

2017 - 2019

Türk Gastroenteroloji Derneği

Secretary General

2013 - 2017

ECCO

Country Representative

Peer Reviews in Scientific Publications

January 2023

FRONTIERS IN MEDICINE

Journal Indexed in SSCI

December 2022

FRONTIERS OF MEDICINE

Journal Indexed in SSCI

Congress and Symposium Activities

26 November 2024 - 01 December 2024

41. Ulusal Gastroenteroloji Haftası

Session Moderator

Antalya-Turkey

26 November 2024 - 01 December 2024

41. Ulusal Gastroenteroloji Haftası

Invited Speaker

Antalya-Turkey

26 November 2024 - 01 December 2024

41. Ulusal Gastroenteroloji Haftası

Moderator

Antalya-Turkey

30 May 2024 - 02 June 2024

İnflamatuvar Barsak HAstalıkları Günleri

Invited Speaker

İstanbul-Turkey

30 May 2024 - 02 June 2024

İnflamatuvar Barsak Hastalıkları Günleri

Session Moderator

İstanbul-Turkey

08 December 2023 - 09 December 2023

Pediatrik - Yetişkin İBH Buluşması

Invited Speaker

Ankara-Turkey

31 May 2023 - 03 June 2023

12. Ulusal İBH Günleri

Session Moderator

İstanbul-Turkey

31 May 2023 - 03 June 2023

12. Ulusal İBH Günleri

Invited Speaker

İstanbul-Turkey

23 November 2022 - 27 November 2022

Ulusal Gastroenteroloji Haftası

Session Moderator

Antalya-Turkey

01 June 2021 - 03 June 2021

İnflamatuvar Barsak Hastalıkları Okulu

Invited Speaker

İstanbul-Turkey

05 June 2015 - 07 June 2015

14. Panhellenic Congress on IBD

Invited Speaker

Athens-Greece

Citations

Total Citations (SCOPUS): 4195

h-index (SCOPUS): 29

Jury Memberships

May-2023

May 2023

Associate Professor Exam

Mustafa Zanyar Akkuzu Eser innceleme - Ankara University

December-2022

December 2022

Appointment to Academic Staff-Assistant Professorship

Dr. Muhammet Fatih Karakaya, Doktor Öğretim Üyeliği Atama - Ankara Üniversitesi

October-2022

October 2022